Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Merck Manuals Addresses Common Misconceptions Around Migraines


KENILWORTH, N.J., Jan. 17, 2019 /PRNewswire/ -- For many migraine sufferers, the onset of a migraine headache can be unexpected, severe and debilitating. While some migraine episodes can be minor, others leave people incapacitated and unable to work or perform daily activities.

What's more, those living with migraines tend to encounter a host of misconceptions, many of which minimize the severity of the disease or fail to acknowledge the challenging treatment landscape. Although more than 12 percent of Americans suffer from migraines, there is a tremendous amount of incorrect or conflicting information that has led to a widespread misunderstanding of the disease.

To provide clarity, Dr. Stephen Silberstein, MD, Director of the Headache Center at the Sidney Kimmel Medical College at Thomas Jefferson University, highlighted four things people should understand about migraines on MerckManuals.com.

1. Migraines run in the family

While a family presence doesn't guarantee someone will suffer migraines, there is a genetic predisposition associated with increased brain sensitivity which often results in the passing on of migraines from one generation to the next. While behavior can trigger individual episodes, migraine is a hereditary disease which is most effectively diagnosed and managed through medical-based treatment options guided by a qualified physician.

2. A migraine is more than a headache

Migraine episodes can cause severe physical symptoms beyond intense head pain, including nausea, dizziness, vomiting, sensitivity to light, gastrointestinal distress, vertigo, and even paralysis in parts of the body.

Yet not all migraines produce these symptoms, which is why many people mistake a migraine for a sinus headache. If a headache presents in the sinus area without fever or congestion, it is likely a migraine. Similarly, mild migraine headaches are often thought to be tension headaches and therefore not treated properly or early enough.

3. Migraines have no gender bias

While there is some perception that migraines are a disease that only affect women, there is no truth to that assertion. Migraines are a disorder of men, women, and children. It is important to understand that migraines are a life altering disease that can affect anyone.

4. There's no silver bullet for migraine treatment

Most migraine sufferers are on a lifelong journey to understand their triggers and find the right combination of routine, diet, and clinical treatments that are the most likely means of controlling their migraine episodes. Many patients seeking relief turn to alternative and emerging therapies such as acupuncture and Botox, which work for some migraine sufferers.

One promising new treatment for the prevention of migraines is called calcitonin gene related peptide (CGRP) antagonist. These drugs are antibodies designed to counteract the effect of the CGRP chemical that comes out of nerve endings in the body ? causing migraines.

Understanding drives action

Migraines are disabling. They interfere with people's social lives, their ability to go to work, and in many cases their ability to live a "normal" life. Making matters worse, migraines are often misunderstood or underestimated by the general public ? and even some physicians. It's critical that a migraine sufferer's family, peers, and healthcare providers take migraines seriously and provide needed support.

About The Merck Manuals and MSD Manuals

First published in 1899 as a small reference book for physicians and pharmacists, The Merck Manual grew in size and scope to become one of the world's most widely used comprehensive medical resources for professionals and consumers. As The Manual evolved, it continually expanded the reach and depth of its offerings to reflect the mission of providing the best medical information to a wide cross-section of users, including medical professionals and students, veterinarians and veterinary students, and consumers. In 2015, The Manuals kicked off Global Medical Knowledge 2020, a program to make the best current medical information accessible by up to three billion professionals and patients around the world by 2020. For access to thousands of medical topics with images, videos and a constantly expanding set of resources, visit MerckManuals.com or MSDManuals.com and connect with us on social media:

For Consumers in the U.S. and its territories: Twitter and Facebook
For Professionals in the U.S. and its territories: Twitter and Facebook

About Merck

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on TwitterFacebookInstagram, YouTube and LinkedIn.

 

SOURCE MerckManuals.com


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: